Vor Biopharma VOR Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 31.1×+12.9× | 18.2×+9.0× | 9.2×+5.7× | 3.5×-0.4× | 3.9×-1.3× | |
| Per Share | ||||||
| Book value per share | -$3.50+79.0% | -$16.64+95.0% | -$333.07-2,671% | -$12.02-214% | $10.59+138% | |
| Valuation | ||||||
| Market capitalization | $784.61M+2,513% | $286.59M-14.2% | $333.92M+740% | $39.75M-55.6% | $89.58M-35.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Vor Biopharma's ratios come from?
- Every ratio is computed from Vor Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.